In January 2024, EYLEA 8mg achieved new heights in Bayer’s mission of 'helping patients see a better life'. You celebrated this major milestone in the EYLEA journey by attending the EYLEA 8mg Global Townhall on January 16, 2024. Either in person in Basel or virtually worldwide. You met the hosts Jan Voss and Zoran Hasanbasic (EYLEA IPT Leads) and the full cross-functional team and learned what they achieved to bring EYLEA 8mg to market, also what the real benefit means to patients and their caregivers. Anne-Grethe Mortensen, Mike Devoy and Stefan Oelrich brought their perspectives and spoke about what this success-story meant to the Pharma division and to the company as a whole. https://www.bayer.com/poap

With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc

We met probably somewhere in between real world and blockchain. I am a former Communications Expert, with a lot of business background, who turned professional of Digital CX & Innovation seeker. Based in Athens, Greece for now.